İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

KAAN KÜÇÜKOĞLU

PROFESÖR

SELÇUK ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 61
  • Proje 0
  • Kitap 0
  • Bildiri 0
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 5 Q2 17 Q3 7 Q4 2
WoS (JCR) Q1 6 Q2 9 Q3 7 Q4 8
TR Index 3 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 7
Ort. yüzdelik 60.8%
Üst %1 payı 0.0%
Üst %10 payı 17.9%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 61 yayın

Scopus (SJR)
Q1 5 Q2 17 Q3 7 Q4 2
WoS (JCR)
Q1 6 Q2 9 Q3 7 Q4 8
TR Index
3 makale

Makale listesi

  1. 2026 Design and synthesis of piperazine-based 3,5-disubstituted-1,2,4-oxadia zole derivatives as dual AChE and BChE inhibitors: In vitro and in silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2026.146605 YÖKSİS SJR Q2 JCR Q2 OpenAlex 44.9%
  2. 2026 Indole-Chalcone-Sulfonamide Hybrids: Synthesis and Dual Biological Evaluation as Anticancer and Antioxidant Agents ChemistrySelect DOI 10.1002/slct.202503713 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 94.9%
  3. 2026 Synthesis and characterization of novel 5-fluoroindolylmethylene hydrazone derivatives as schiff base compounds: In vitro and in silico evaluation as potential cholinesterase (AChE and BChE) inhibitors Journal of the Indian Chemical Society DOI 10.1016/j.jics.2026.102484 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.9%
  4. 2024 Design, synthesis, and molecular docking studies of benzimidazole-1,3,4-triazole hybrids as carbonic anhydrase I and II inhibitors Chemical Biology & Drug Design DOI 10.1111/cbdd.14351 YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.0%
  5. 2024 Design, synthesis and biological evaluation of novel ketone derivatives containing benzimidazole and 1,3,4-triazole as CA inhibitors Journal of Molecular Structure DOI 10.1016/j.molstruc.2023.136770 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.8%
  6. 2024 Novel Hydrazide-Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes Chemical Biology Drug Design DOI 10.1111/cbdd.70025 YÖKSİS SJR Q2 JCR Q2 OpenAlex 50.9%
  7. 2023 Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents Journal of Molecular Structure DOI 10.1016/j.molstruc.2022.134699 YÖKSİS SJR Q2 JCR Q2 OpenAlex 66.9%
  8. 2023 Synthesis and Molecular Docking of New N-Acyl Hydrazones-Benzimidazole as hCA I and II Inhibitors Medicinal Chemistry DOI 10.2174/1573406419666221222143530 YÖKSİS SJR Q3 JCR Q3 OpenAlex 39.8%
  9. 2022 Design, synthesis, and molecular docking studies of novel benzimidazole-1,3,4-oxadiazole hybrids for their carbonic anhydrase inhibitory and antioxidant effects Medicinal Chemistry Research DOI 10.1007/s00044-022-02943-6 YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.8%
  10. 2019 In silico Molecular Docking and ADME Studies of 1,3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity Current Computer-Aided Drug Design DOI 10.2174/1573409914666180518085908 YÖKSİS SJR Q3 JCR Q4 OpenAlex 46.2%
  11. 2019 Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes BIOORGANIC CHEMISTRY DOI 10.1016/j.bioorg.2019.02.008 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.2%
  12. 2018 Cytotoxicities of novel hydrazone compounds with pyrrolidine moiety: inhibition of mitochondrial respiration may be a possible mechanism of action for the cytotoxicity of new hydrazones Medicinal Chemistry Research DOI 10.1007/s00044-018-2220-y YÖKSİS SJR Q2 JCR Q4 OpenAlex 58.3%
  13. 2017 Some N-(5-methyl-1,3,4-thiadiazol-2-yl)-4-[(3-substituted) ureido/thioureido]benzenesulfonamides as carbonic anhydrase I and II inhibitors Marmara Pharmaceutical Journal DOI 10.12991/marupj.259885 YÖKSİS TR Index SJR Q3 OpenAlex 63.4%
  14. 2017 Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives Bioorganic medicinal chemistry DOI 10.1016/j.bmc.2017.05.005 YÖKSİS SJR Q1 JCR Q2 OpenAlex 78.1%
  15. 2017 Microwave-assisted synthesis and bioevaluation of new sulfonamides Journal of Enzyme Inhibition and Medicinal Chemistry DOI 10.1080/14756366.2016.1254207 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.3%
  16. 2017 Synthesis and evaluation of novel 2-[(1,2,4-triazol-3-yl)thio]acetamide derivatives as potential serum paraoxonase-1 (PON1) activators Marmara Pharmaceutical Journal DOI 10.12991/mpj.2017.19 YÖKSİS TR Index SJR Q3 OpenAlex 52.7%
  17. 2017 Synthesis and Evaluation of New Benzodioxole Based Dithiocarbamate Derivatives as Potential Anticancer Agents and hCA I and hCA II Inhibitors European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2016.09.035 YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.8%
  18. 2016 Synthesis and antimicrobial activity evaluation of new dithiocarbamate derivatives bearing thiazole benzothiazole rings Phosphorus, Sulfur, and Silicon and the Related Elements DOI 10.1080/10426507.2016.1150277 YÖKSİS SJR Q4 JCR Q4 OpenAlex 89.9%
  19. 2016 Synthesis of 4 2 substituted hydrazinyl benzenesulfonamides and their carbonic anhydrase inhibitory effects Journal of Enzyme Inhibition and Medicinal Chemistry DOI 10.3109/14756366.2015.1047359 YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 97.5%
  20. 2016 Cytotoxicity of Hydrazones of Morpholine Bearing Mannich Bases towards Huh7 and T47D Cell lines and Their Effects on Mitochondrial Respiration Letters in Drug Design & Discovery DOI 10.2174/1570180813666160113002907 YÖKSİS SJR Q2 JCR Q4 OpenAlex 76.7%

Akademisyenlere dön